References
- Natarajan H, Kumar L, Bakhshi S, et al. Imatinib trough levels: a potential biomarker to predict cytogenetic and molecular response in newly diagnosed patients with chronic myeloid leukemia. Leuk Lymphoma. 2018 Aug 20:1-8. doi:10.1080/10428194.2018.1485907. [Epub ahead of print].
- Imatinib mesylate: view uses, side effects and medicines | 1mg. [cited 2018 Dec 28]. Available from: https://www.1mg.com/generics/imatinib-mesylate-212752
- Nilotinib: view uses, side effects and medicines | 1mg. [cited 2018 Dec 28]. Available from: https://www.1mg.com/generics/nilotinib-404953
- Dasatinib: view uses, side effects and medicines | 1mg. [cited 2018 Dec 28]. Available from: https://www.1mg.com/generics/dasatinib-212957
- National Health Profile 2018; 13th Issue. Central Bureau of Health Intelligence, Directorate General of Health Services, Ministry of Health & Family Welfare, Government of India; 2018 [cited 2018 Dec 27]. Available from: https://cbhidghs.nic.in/index1.php?lang=1&level=2&sublinkid=88&lid=1138
- The World Bank. Out-of-pocket expenditure (% of current health expenditure) | Data. [cited 2018 Dec 28]. Available from: https://data.worldbank.org/indicator/SH.XPD.OOPC.CH.ZS?locations=IN